Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
TNFRSF12A VHH recombinant monoclonal antibody
TNFRSF18 VHH recombinant monoclonal antibody
TNFRSF4 VHH recombinant monoclonal antibody
TNFSF11 VHH recombinant monoclonal antibody
TNFSF13 VHH recombinant monoclonal antibody
TNFSF13B VHH recombinant monoclonal antibody
TNFSF14 VHH recombinant monoclonal antibody
TNFSF15 VHH recombinant monoclonal antibody
TNFSF4 VHH recombinant monoclonal antibody
TPBG VHH recombinant monoclonal antibody
TSLP VHH recombinant monoclonal antibody
TYRP1 VHH recombinant monoclonal antibody